Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Trelleborg Group management subscribe for options

Trelleborg’s Group management, comprising nine individuals including the President and CEO, have subscribed for a total of 150,000 call options in Trelleborg AB. Trelleborg’s principal owner, Henry Dunker Donation Fund & Foundations, has via AB Hevea offered Group management the opportunity to subscribe for options. Trelleborg AB did not participate in the offer and will not be charged with any earnings effect related to the program.  Group management acquired 12,500 call options each, except the President and CEO who acquired 50,000 call options, at a price of SEK 9.86 per call

Caverion acquires Jetitek Oy to boost its cooling expertise and services

Caverion Corporation Investor news 19 November 2018 at 9:40 a.m. EETCaverion acquires Jetitek Oy to boost its cooling expertise and services Caverion Suomi Oy has signed an agreement to acquire the entire share capital of Jetitek Oy from the management of the company. Jetitek is a Finnish service company specialised in energy-efficient cooling solutions that offers total deliveries of refrigeration systems and their design and dimensioning as well as maintenance, repair, and alterations.  Jetitek's revenue is expected to reach over EUR 15 million in 2018, and it employs 54

Leading broadcaster Euronews signs agreement with Cxense

Oslo, Norway – 19 November 2018 – Cxense ASA (OSE: CXENSE) today announced that Euronews, the no 1. European news channel, signed an agreement to use Cxense DMP and personalization software.Euronews holds a leading position in continental Europe in terms of reach. Every day, more than 50 million TV viewers and digital consumers use the company’s outlets, according to Global Web Index. Euronews is a widely recognized global brand and its TV- and digital channels reach more than 430 million homes across 166 countries.Euronews will use Cxense to gain insights into audience behaviour across

SCA issues bonds for SEK 1 billion

On Friday the 16th of November Svenska Cellulosa Aktiebolaget SCA (publ) issued bonds under the companys Medium Term Note programme (MTN).The total amount was SEK 1 billion and the bond runs with floating interest rates. The bonds have a tenor of 2 years and the interest rate margin was set to 0.41% per annum.SEB and Swedbank are Joint Bookrunners for the issue. The bonds will be listed on Nasdaq Stockholm.  For further information, please contact: Björn Lyngfelt, Vice President Group Communication, +46 60 19 34 98Toby Lawton, CFO, +46 60 19 31 09 The core of SCA’s business is

Japanese printing and media group Dai Nippon Printing signs agreement for Conversion Engine

Oslo, Norway – 19 November 2018 – Cxense ASA (OSE: CXENSE) today announced that Dai Nippon Printing Co., Ltd. (DNP), a diversified Japanese group engaged in printing, electronic components, information and media supplies signed an agreement to use Cxense Conversion Engine.Tokyo-based DNP has more than 10,000 employees and extensive operations in Japan and other Asian countries, as well as a presence in Europe, the US and Australia. Besides providing printing services and manufacturing electronic components, the company also offers a wide range of digital services within publication, web

Konftel launches video conferencing packages with unique One Cable Connection

Konftel, a global leader in the manufacture of conference telephones, is now ready to begin selling its new range of packages that take all the hassle out of video conferences. “It’s high time the world’s workplaces had access to simple video solutions. It’s video for the people, basically,” says Peter Renkel, CEO of Konftel. “Historically, video conferencing has been rather odd and convoluted, but it doesn’t have to be that way. We’ve solved the problem in a really smart and cost-effective way.”Common to all of Konftel’s new video packages is their support for Bring Your Own Meeting,

Smart Eye rewarded four more design wins from an existing customer

Smart Eye has been awarded four more design wins from an existing customer. It’s for additional car models on the same platform where one design win has already been awarded. The European premium car manufacturer will launch these additional four car models with driver monitoring systems in the period 2019 to 2020.The order value is estimated to exceed 125 MSEK for the four car models based on product life cycle volume projections. A successful migration of the initial five cars to subsequent car models for the same platform may lead to a total estimated revenue exceeding 450 MSEK over the

Tecnotree completes co-operation negotiations in Finland

Tecnotree CorporationStock Exchange Release19 November 2018 at 9.00 am EESTTecnotree completes co-operation negotiations in FinlandThe co-operation negotiations started on the10th October, 2018 have been completed. The negotiations concerned the whole personnel in Finland.The personnel reduction in Finland will be in total 26 employees of which 16 via lay-offs and 10 via other measures. These measures will lead to EUR 2 million cost savings per annum and will be realized in full in the year of 2019. TECNOTREE CORPORATIONFURTHER INFORMATIONPadma Ravichander, CEO, tel. +971 56

Ascelia Pharma receives positive feedback from FDA on design of the pivotal Phase 3 study with Mangoral®

Ascelia Pharma AB today announced that the company has successfully concluded discussions with the US Food and Drug Administration (FDA) regarding the study design for the single pivotal Phase 3 trial for Mangoral® as a contrast agent in patients with focal liver lesions and severe renal impairment.  Ascelia Pharma will now complete the preparatory work to start the trial and expects to enroll the first patient during the second half of 2019.Mangoral® is an oral contrast agent for liver MRI developed to facilitate the visualization of focal liver lesions, including liver metastases, using

Per Hove is appointed new CEO of EVRY

Per Hove (52) has been the head of EVRY Norway since June 2018. He is taking over as Group CEO from Björn Ivroth with immediate effect.Per Hove joined EVRY as Sales Director in 2015. He subsequently became Executive Vice President in Sept 2017 and has been head of both Digital Platform Services and BA Norway. Per Hove’s previous roles include Country Manager for Oracle Norway as well as Country Manager for HCL in Norway, which he built into a billion-krone business over a five-year period. “With over 20 years’ experience in IT and technology companies, Per Hove has significant

Isofol Strengthens Executive Management Team with the Appointment of Roger Tell, MD, PhD, as Chief Scientific Officer and Senior Vice President of Clinical Development

GOTHENBURG, Sweden, November 19, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the recruitment of Roger Tell, MD., PhD as Chief Scientific Officer (CSO) and Senior Vice President (SVP) of clinical development. Dr. Tell has more than a decade of experience as a clinical oncologist in addition to holding management and advisory positions at Eli Lilly, AstraZeneca, Merck, Servier and Aprea Therapeutics. As the new chief scientific officer, Dr. Tell will be in charge of scientific research and technical operations at Isofol. Dr. Tell will also be involved

InDex Pharmaceuticals Holding AB (publ) interim report January – September 2018

Directed share issue strengthens the cash position ahead of the CONDUCT resultsPeriod July – September 2018   · Revenues amounted to SEK 0.0 (0.0) million · Operating result amounted to SEK –15.1 (–13.3) million · Result after tax amounted to SEK –15.1 (–13.1) million, corresponding to SEK –0.24 per share (–0.21) before and after dilution · Cash flow from operating activities amounted to SEK –16.1 (–16.6) million Period January –September 2018 · Revenues amounted to SEK 0.1 (0.1) million · Operating result amounted to SEK –59.9 (–50.7) million · Result after tax

BONESUPPORT™ - POSITIVE RESULTS FROM THE CERTiFy STUDY COMPARING CERAMENT®|BONE VOID FILLER WITH AUTOGRAFT

Lund, Sweden, 08.00 CET, 19 November 2018 – BONESUPPORTTM, an emerging leader in orthobiologics for the management of bone voids, today announces positive top-line data from the CERTiFy (CERAMENT® Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft). BONESUPPORT CEO Emil Billback said:” Successfully completing the ground-breaking CERTiFy study, to demonstrate CERAMENT BVF is non-inferior to autograft in treating tibia plateau fracture defects, is a major milestone for BONESUPPORT. We expect the results from the study to

Tele2 appoints Kim Hagberg to the Leadership Team

Stockholm – Tele2 AB (Tele2) (Nasdaq Stockholm: TEL2 A and TEL2 B) appoints Kim Hagberg as Executive Vice President, Chief Operations and member of the Leadership Team, reporting to Anders Nilsson, President and CEO, effective as of today.Since Tele2 announced the merger with Com Hem in January 2018, Kim Hagberg has played an essential role in planning and managing the large integration processes, encompassing several areas of expertise. In her new role as EVP, Chief Operations, Kim will continue those efforts and make sure the processes of Tele2 and former Com Hem can be harmonized in a

EVRY ASA: Per Hove appointed as new CEO of EVRY ASA

(Fornebu, 19 November 2018) EVRY ASA is pleased to announce that Per Hove (52) has accepted the position as new Group Chief Executive Officer of EVRY. Per Hove replaces Björn Ivroth, who announced his intention to retire from the company on 16 July 2018. EVRY Board of Directors has assessed external and internal candidates in the process to find Ivroth’s successor. Per Hove has been with EVRY since 2015, where he lately has been holding the position as EVP of EVRY Norway. He has more than 20 years of extensive experience from digitalisation and change management in the IT and Software

Redeye: Aspire Global - Strong momentum

Aspire Global beat our expectations in Q3. Both revenues and EBITDA came in well ahead. We believe that the market has underestimated the effects of Aspire Global´s improvement program. It is clear that these improvements have paved the way for the strong underlying growth trend, easily surpassing market growth rates. As a consequence, we have updated our estimates, which results in a new fair value of SEK 62 per share in Base case.  

Share buy-backs in Telia Company during week 46 2018

During the period November 12, 2018 - November 16, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 5 215 000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018 and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

GoldBlue AB (publ) executes a 100 percent guaranteed new issue of shares with preferential rights for existing shareholders

Stockholm, 19 Nov 2018 07:00 CET This press release must not be announced, published or distributed, either directly or indirectly, in or to the United States, Canada, Australia, Hong Kong, Japan, New Zealand, Switzerland, Singapore or South Africa. GoldBlue's Board, based on the authorization of the Annual General Meeting of June 20, 2018, resolved to issue a new issue of shares and warrants with preferential rights for existing shareholders ("new share issue") of approximately SEK 14.2 million before issue costs. In full exercise of the warrants issued with exercise window at

Ahlstrom-Munksjö publishes pro forma financial information related to the acquisition of Expera and Caieiras and additional selected financial information on Expera

AHLSTROM-MUNKSJÖ OYJ, STOCK EXCHANGE RELEASE November 19, 2018 at 08:00 a.m. EET This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, South Africa or the United States or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be completed or registered or require any measure to be undertaken, in addition to the requirements under Finnish law. For further information, see “Important notice” below.

Skeletal imitation reveals how bones grow atom-by-atom

Researchers from Chalmers University of Technology, Sweden, have discovered how our bones grow at an atomic level, showing how an unstructured mass orders itself into a perfectly arranged bone structure. The discovery offers new insights, which could yield improved new implants, as well as increasing our knowledge of bone diseases such as osteoporosis.The bones in our body grow through several stages, with atoms and molecules joining together, and those bigger groupings joining together in turn. One early stage in the growth process is when calcium phosphate molecules crystallise, which

Students interpret the world through the photo media in a new exhibition in Malmö

On Friday the 23rd of November the group show “Rest Assured in Unknown Places” will open at Galleri Format in Malmö. The exhibition features nine international artists currently studying on the last year of the MFA Programme in Photography at Valand Academy, University of Gothenburg.The presented works are made using various approaches – from archival material and found images, to the creation of a dialogue between the visual and the written. – The title “Rest Assured in Unknown Places” refers to some of the theories we've been learning about during our study process. It reflects the

Report for the period 1 January - 30 September 2018

1 July- 30 September · Consolidated net sales amounted to 7 888 TSEK (15 063) · Net operating income amounted to 276 TSEK (7 611) · Operating profit amounted to -1 617 TSEK (5 995) · Net profit for the period amounted to -8 404 TSEK (491) · Earnings per share before and after dilution effects amounted to -16,81 SEK (0,98) 1 January - 30 September · Consolidated net sales amounted to 29 634 TSEK (47 183) · Net operating income amounted to 7 646 TSEK (20 830) · Operating profit amounted to -16 063 TSEK (14 101) · Net profit for the period amounted to -32 171

NattoPharma Market Update

Q3 revenue increases by more than 60% on a Q by Q comparisonOslo, Norway (19 November 2018) — NattoPharma reports operating revenues for the third quarter of 2018 of NOK 24,6 million, adjusted for non-product related revenue NOK 23,6 million. This represents growth of 61% compared to the third quarter of 2017. During the same period gross margin has developed positively to 45%, up from 42% in Q2, resulting in a year to date gross margin of 43%. all numbers in NOK million Q3 YTD 2018 2017 2018 2017Product Revenue 23,6 14,7 70,8

There are no items matching the current filter
There are no more items matching the current filter
Back to top